AaronPatrickTansyMD
Neurology • South Plainfield, NJNeuroimaging, Vascular Neurology, Neurodegenerative
Sr. Medical Director, Clinical Development PTC Therapeutics, Inc.
Dr. Tansy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Corporate Court
South Plainfield, NJ 07080- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Vascular Neurology, 2012 - 2013
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2006 - 2009- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2005 - 2008
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 2005 - 2006
Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
NY State Medical License 2006 - 2026- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Clinical Trials
- Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS Start of enrollment: 2022 May 15
- A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria Start of enrollment: 2022 Feb 14
- A Study of PTC923 in Participants With Phenylketonuria Start of enrollment: 2021 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFirst-in-Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15-Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis.Lan Gao, Peter Giannousis, Martin Thoolen, Diksha Kaushik, Joey Latham, Aaron Tansy, Jiyuan Ma, Mayzie Johnston, Mandar Dali, Lee Golden, Matthew Klein, Ronald Kong, J...> ;Clinical Pharmacology in Drug Development. 2023 Feb 1
- Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Diseas...Bernstein RA, Kamel H, Granger CB, Piccini JP, Sethi PP, Katz JM, Vives CA, Ziegler PD, Franco NC, Schwamm LH, STROKE-AF Investigators> ;JAMA.
- Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized C...Schwamm LH, Kamel H, Granger CB, Piccini JP, Katz JM, Sethi PP, Sidorov EV, Kasner SE, Silverman SB, Merriam TT, Franco N, Ziegler PD, Bernstein RA, STROKE AF Investig...> ;JAMA neurology. 2022-11-14
- Join now to see all
Professional Memberships
- Member
External Links
- PTC Therapeutics http://www.ptcbio.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
